{
    "2018-04-12": [
        [
            {
                "time": "2023-04-12",
                "original_text": "医药板块业绩进入兑现期 两股或迎来主升",
                "features": {
                    "keywords": [
                        "医药板块",
                        "业绩兑现",
                        "主升"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-12",
                "original_text": "医药行业周观点:中美贸易摩擦加剧,建议防御性配置恒瑞医药、美年健康、乐普医疗、爱尔眼科等医药行业龙头企业",
                "features": {
                    "keywords": [
                        "中美贸易摩擦",
                        "防御性配置",
                        "恒瑞医药",
                        "美年健康",
                        "乐普医疗",
                        "爱尔眼科"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}